-0.000133982403644326 0.00022330400607392 -0.000223304006073793 0.000848555223080692 0.00303693448260465 0.00500200973605469 0.00602920816399444 0.00576124335670591
Sign Up Today X
Thanks for submitting the form.
Stockreport

Why California's biopharma boom is critical for logistics [Yahoo! Finance]

Gilead Sciences, Inc. (GILD)  More Company Research Source: Yahoo! Finance
Last gilead sciences, inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.gilead.com
California is quietly staging a pharmaceutical renaissance, not of arts or culture this time, but of science, supply chains, and life-changing therapies. As the backbone of biopharma innovation in the U.S., the Golden State is becoming a place of industry transformation, embodied most recently by investments from Amgen and Gilead. A hub for pioneer science Amgen's recent investment of $600 million to build a cutting-edge science and innovation center at its global headquarters in Thousand Oaks, CA. More than a building, this is designed to bring together scientists, engineers, and researchers in one digitally enabled, automated hub. The goal? To turbocharge discovery pipelines and reinforce the U.S. as the leading stage for next-generation therapeutics. This investment aligns closely with Amgen's broader strategy. Since the 2017 Tax Cuts and Jobs Act and its reinforcement through the 2025 One Big Beautiful Bill, the company has funneled over $40 billion into domestic manufact [Read more]
IMPACT SNAPSHOT EVENT TIME: GILD
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
GILD alerts
from News Quantified
GILD
NEWS
GILD
Earnings
GILD
Analyst Actions
GILD
SEC Filings
Stockreport

Why California's biopharma boom is critical for logistics [Yahoo! Finance]

Gilead Sciences, Inc.  (GILD) 
More Company Research Source: Yahoo! Finance
Last gilead sciences, inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.gilead.com
California is quietly staging a pharmaceutical renaissance, not of arts or culture this time, but of science, supply chains, and life-changing therapies. As the backbone of biopharma innovation in the U.S., the Golden State is becoming a place of industry transformation, embodied most recently by investments from Amgen and Gilead. A hub for pioneer science Amgen's recent investment of $600 million to build a cutting-edge science and innovation center at its global headquarters in Thousand Oaks, CA. More than a building, this is designed to bring together scientists, engineers, and researchers in one digitally enabled, automated hub. The goal? To turbocharge discovery pipelines and reinforce the U.S. as the leading stage for next-generation therapeutics. This investment aligns closely with Amgen's broader strategy. Since the 2017 Tax Cuts and Jobs Act and its reinforcement through the 2025 One Big Beautiful Bill, the company has funneled over $40 billion into domestic manufact [Read more]
IMPACT SNAPSHOT
EVENT TIME:
GILD
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Don't Miss Out On The Next BIG Stock Move
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS